Wegovy 2.4 mg Pen: Understanding the Maintenance Dose

Wegovy (semaglutide) is a once-weekly injectable medicine that is typically started at a low dose and increased gradually. According to the electronic Medicines Compendium (eMC), the titration schedule progresses through several dose strengths — starting at 0.25 mg and moving upward at intervals set by your prescriber — before reaching the 2.4 mg maintenance dose.

The dose strengths in context

Commonly referenced Wegovy dose strengths include 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Each is supplied as a separate pre-filled pen device. The gradual step-up approach is designed to allow the body time to adjust, with the aim of minimising side effects as the dose increases.

• The 0.5 mg pen is an early titration step many people pass through on the way up.
• The 1.7 mg pen is the step immediately before the 2.4 mg maintenance dose.
• For a broader overview of all the dose stages, see the guide to Wegovy dose strengths and what they mean.

What changes at 2.4 mg

Many people report that appetite suppression and the reduction in "food noise" are more pronounced at higher doses, though individual responses vary considerably. Some people also notice that side effects — particularly gastrointestinal ones such as nausea, constipation, or reflux — can resurface or intensify with each dose increase, including the move to 2.4 mg. These effects are commonly reported and often ease over time, but if they are severe or persistent, contact your healthcare professional promptly.

The 1 mg pen and 1.7 mg pen are part of the same titration pathway; the 1 mg strength bridges the earlier stages to the upper range of the schedule. Your prescriber will determine which pen you are using at any given point and whether progressing to 2.4 mg is appropriate for you.

Keeping an accurate record of where you are in your dose schedule matters — especially across a titration journey that spans months and multiple pen strengths. GLP Trackr's dose logging feature lets you record each injection with its date, time, and dose strength, so you always have a clear, timestamped history of your treatment to refer back to or share with your prescriber.

The app also includes dose reminders, so your weekly injection day stays on track even when life gets busy. Missing a dose is something worth logging too — GLP Trackr lets you note it so you can discuss with your prescriber exactly what happened and what to do next. Any decision about a missed or upcoming dose belongs with your prescriber, not a self-management workaround.

If you experience side effects as your dose increases — nausea, fatigue, digestive changes — the side-effect tracking feature lets you log how you feel alongside your dose history. Over time, patterns can emerge that are genuinely useful to bring to a prescriber appointment. You can also generate a summary report directly from the app to support those conversations.

For broader guidance on managing your treatment schedule, the GLP-1 dosing hub covers key topics across the journey.

Always follow the guidance of your prescriber or doctor — they know your full history and are best placed to make any decision about your dose. If you experience symptoms that feel severe, persistent, or worrying at any dose stage, seek advice from a healthcare professional promptly. Any side effects worth reporting can be submitted to your national reporting scheme (such as the UK's Yellow Card scheme) as well as to your own prescriber.

Ready to keep your dose history in one place? Download GLP Trackr on the App Store or Google Play and try it free for 7 days — your injection log, reminders, and side-effect tracker are all waiting.